Impact of mirikizumab maintenance dosing on patients who had < PASI 90 response at week 16: A phase 2 study analysis using the DLQI

2019 ◽  
Vol 81 (4) ◽  
pp. AB223
Keyword(s):  
Phase 2 ◽  
2020 ◽  
Vol 158 (6) ◽  
pp. S-1204-S-1205
Author(s):  
Gary R. Lichtenstein ◽  
Brian G. Feagan ◽  
Jay Tuttle ◽  
Nathan Morris ◽  
Yan Dong ◽  
...  

2020 ◽  
Vol 13 (8) ◽  
pp. 100429
Author(s):  
Emma Guttman-Yassky ◽  
Ana B. Pavel ◽  
Jonathan Silverberg ◽  
Stephan Weidinger ◽  
Julie Parmentier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document